Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Anger at withdrawal of Boots suncare licences

Boots will make its revised "star-rating" licences for sun cream available to all suncare brands "shortly", after it withdrew them from competitors ahead of changing its system. The multiple made the statement following anger from competitors over the decision.

However, Boots has yet to explain how the system's standards had been changed. The multiple withdrew the licences from competitors' suncare brands, but said it had worked with Cancer Research UK to establish "more robust controls to deal with past issues of non-compliance to the star-rating system, so that customers can be sure that any brand using this system is doing so correctly".

Cancer Research UK also declined to give details, saying only that it had "exchanged letters on the matter", with Boots.

The decision to withdraw the licences provoked anger among competitors including Sainsbury's, Asda and Superdrug.

Sainsbury's said it was "disappointed" by Boots' decision to withdraw the licence from its suncare products and reassured customers that its own-brand suncreams were rated five-star.

Superdrug echoed the comments and called for an independent standard on suncare products, "not one regulated by a retailer". "Our own brand suncare continues to conform to the five-star standard, yet we can't reassure our customers by using the rating system," said Superdrug brand director Andrew Groom.   

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD014284

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel